GlassScriptPhysician profile
David J Sales
NPI 1164412508
$22,258.18
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $5,066.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $11,036.04 | 2019-2020 | |
| Abbvie INC. | $10,156.36 | 2019-2020 | |
| Janssen Biotech, INC. | $231.66 | 2019-2020 | |
| Braintree Laboratories, INC. | $168.58 | 2019-2020 | |
| Allergan, INC. | $160.62 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $126.44 | 2019-2020 | |
| Ucb, INC. | $117.78 | 2019-2020 | |
| Pfizer INC. | $57.06 | 2019 | |
| Qol Medical, LLC | $41.19 | 2019 | |
| Shire North American Group INC | $31.21 | 2019 | |
| Boston Scientific Corporation | $30.51 | 2019 | |
| Merck Sharp & Dohme LLC | $28.05 | 2019 | |
| Endo Pharmaceuticals INC. | $23.60 | 2019 | |
| Ironwood Pharmaceuticals, INC | $18.12 | 2019 | |
| Romark Laboratories, Lc | $15.71 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $15.25 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.